Never has so much data been available—but those in medicine face the ongoing challenge of making the most of what’s available. A new report from Deloitte examined just how medical technology companies can improve outcomes, reduce costs and bolster efficiency.

SOC Telemed, the nation’s largest national provider of telemedicine technology to healthcare providers, has acquired behavioral health telemedicine company JSA Health.

A research team was able to successfully attack a patient monitoring system to emulate and modify vital signs in real-time. 

Seattle, Boston, Atlanta, New York and Columbus, Ohio, are just a handful of cities seeing hospitals enter the real estate space in a community-based approach to healthcare, NPR reported.

More benefits are coming to Medicare Advantage plans aimed at keeping older Americans in their homes longer, but the uncertainty around these additions—and their cost—means more scrutiny may be needed, according to the Bipartisan Policy Center.

A team of Australian researchers found those who consulted online resources had better interactions, because it led to more informed discussions while not undermining trust in diagnoses and treatment plans. Still, while the activity was generally considered positive, searches could increase patient anxiety.

A team of Australian researchers found those who consulted online resources had better interactions, because it led to more informed discussions while not undermining trust in diagnoses and treatment plans. Still, while the activity was generally considered positive, searches could increase patient anxiety.

Anthem, Inc.'s $115 million settlement for a data breach that exposed the personal information of millions has been approved by a federal judge, according to a report by Bloomberg Law.

Health insurance company Anthem has teamed up with Walmart in a bid to improve access to and lower the price of over-the-counter (OTC) medicines and services, the companies announced Monday.

BrainsWay recently received de novo clearance from the U.S. Food and Drug Administration (FDA) for its deep transcranial magnetic stimulation (Deep TMS) system for treating obsessive compulsive disorder (OCD) in adults.